Investment

Features

Pro Tools for Pro Traders

Uncover the powerful trading features

Pro Features

Pluang Web Trading

Leverage

Built for Investors

Experience investing with simplified features

Pockets

Recurring Buy

USD Yield

Pluang Cuan

Fees

Safety

Academy

Latest for You

Get up-to-date financial news and investing tips & information

Blog

Find various tips & information to become a knowledgeable investor

News and Analysis

Read the latest information about finance and investment

Learn

Become a smarter investor by learning the basics of investing

Glossary

Learn investment terms to understand investing better

Promo & Referral

Discover exclusive opportunities to level up your investments

Investment Clubs (Coming Soon)

Join hands with like-minded investors to grow wealth together

Press (Coming Soon)

Stay updated with our latest news and media coverage

Support

About Us

Contact

Ask

Career

Tax Reporting Guide

Pluang+

Becton Dickinson and Co (BDX) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Technical Indicators

Overall Summary

Bearish (2)

Neutral (12)

Bullish (13)

Performance

BDX ROI

-11.5%

% from 52W High

-12.38%

$234.15

52W Low: $221.47

09 Jul 2024

52W High: $267.23

10 Oct 2023

News

Globe Newswire

14d

Breast Biopsy Research Analysis Report 2024 - Global Market to Reach $2.08 Billion - Rising Momentum of Liquid Biopsy, Incorporation of Minimally Invasive Breast Biopsies

Globe Newswire

22d

Influenza Diagnostics Business Research Report 2024: Innovation in Multiplex Assays Generates Opportunities

Globe Newswire

Global Cancer Biomarkers Market to Surge from USD 22.78 Billion in 2023 to USD 82.66 Billion by 2033, Achieving a CAGR of 13.76%

Globe Newswire

Catheters Market Set to Reach USD 99.30 Billion by 2032, Growing at a CAGR of 7.2% | Polaris Market Research

Globe Newswire

Home Infusion Therapy Market Forecast and Company Analysis Report 2024-2032

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions